Literature DB >> 24913806

Correlation between OPN gene polymorphisms and the risk of nasopharyngeal carcinoma.

Jun-li Wang1, Le-gen Nong, Yu-jin Tang, Ye-sheng Wei, Feng-lian Yang, Chun-fang Wang.   

Abstract

Previous studies suggest that osteopontin (OPN) levels are associated with the incidence and development of multiple types of cancer. This study analyzes the correlation between OPN gene variants and nasopharyngeal carcinoma (NPC). A total of 150 NPC patients and 150 healthy adults were enrolled and divided into NPC and control groups. In both groups, four OPN polymorphisms including rs1126772, rs4754, rs11728697 and rs9138 were quantitatively genotyped by SNaPshot SNP genotyping assay. Allele frequencies of four OPN polymorphisms were compared between two groups. No statistical significance was noted regarding genotype frequency of four OPN polymorphisms between male NPC and healthy subjects (all P > 0.05). Female subjects between two groups significantly differed in terms of genotype frequency of rs1172869 (P = 0.002). No statistical significance was observed in allele frequencies in each of four OPN polymorphisms between two groups (all P > 0.05). For NPC patients, the polymorphisms information content (PIC) ranged from 0.2961 to 0.3584 and 0.3047 to 0.3655 for normal controls. Additionally, rs11728697 had the highest effective number of alleles (Ne), expected heterozygosity (HE) and PIC in two groups. Female subjects in two groups significantly differed in the genotype frequency of rs1172869 while no statistical significance was noted for male counterparts. All subjects in the NPC and control groups had similar allele frequency. All the four OPN polymorphisms were moderately polymorphic. The mean NA, Ne, Ho, He and PIC of each OPN polymorphism in the control group were higher than those in the NPC group without a significant difference.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24913806     DOI: 10.1007/s12032-014-0020-x

Source DB:  PubMed          Journal:  Med Oncol        ISSN: 1357-0560            Impact factor:   3.064


  16 in total

1.  A polymorphic variant inside the osteopontin gene shows association with disease course in oligoarticular juvenile idiopathic arthritis.

Authors:  R Marciano; F Giacopelli; M T Divizia; M Gattorno; E Felici; A Pistorio; A Martini; R Ravazzolo; P Picco
Journal:  Ann Rheum Dis       Date:  2005-09-08       Impact factor: 19.103

2.  Osteopontin expression in nasopharyngeal carcinoma: its relevance to the clinical stage of the disease.

Authors:  Hong-Han Wang; Xing-Wei Wang; Can-E Tang
Journal:  J Cancer Res Ther       Date:  2011 Apr-Jun       Impact factor: 1.805

3.  Osteopontin as a potential diagnostic biomarker for ovarian cancer.

Authors:  Jae-Hoon Kim; Steven J Skates; Toshimitsu Uede; Kwong-kwok Wong; John O Schorge; Colleen M Feltmate; Ross S Berkowitz; Daniel W Cramer; Samuel C Mok
Journal:  JAMA       Date:  2002-04-03       Impact factor: 56.272

4.  Osteopontin promotes integrin activation through outside-in and inside-out mechanisms: OPN-CD44V interaction enhances survival in gastrointestinal cancer cells.

Authors:  Jia-Lin Lee; Mei-Jung Wang; Putty-Reddy Sudhir; Gen-Der Chen; Chin-Wen Chi; Jeou-Yuan Chen
Journal:  Cancer Res       Date:  2007-03-01       Impact factor: 12.701

Review 5.  The functional and clinical roles of osteopontin in cancer and metastasis.

Authors:  K A Furger; R K Menon; A B Tuck; V H Bramwell; A F Chambers
Journal:  Curr Mol Med       Date:  2001-11       Impact factor: 2.222

6.  Osteopontin polymorphisms and disease course in multiple sclerosis.

Authors:  S Caillier; L F Barcellos; S E Baranzini; A Swerdlin; R R Lincoln; L Steinman; E Martin; J L Haines; M Pericak-Vance; S L Hauser; J R Oksenberg
Journal:  Genes Immun       Date:  2003-06       Impact factor: 2.676

7.  Expression of osteopontin, a target gene of de-regulated Wnt signaling, predicts survival in colon cancer.

Authors:  Franziska Rohde; Caroline Rimkus; Jan Friederichs; Robert Rosenberg; Carmen Marthen; Dietrich Doll; Bernhard Holzmann; Jörg-Rüdiger Siewert; Klaus-Peter Janssen
Journal:  Int J Cancer       Date:  2007-10-15       Impact factor: 7.396

8.  Elevated circulating level of osteopontin is associated with advanced disease state of non-small cell lung cancer.

Authors:  Yoon Soo Chang; Hyung Jung Kim; Joon Chang; Chul Min Ahn; Sung Kyu Kim; Se Kyu Kim
Journal:  Lung Cancer       Date:  2007-05-21       Impact factor: 5.705

9.  Association of osteopontin gene haplotypes with nephrolithiasis.

Authors:  B Gao; T Yasui; Y Itoh; Z Li; A Okada; K Tozawa; Y Hayashi; K Kohri
Journal:  Kidney Int       Date:  2007-05-23       Impact factor: 10.612

10.  Genetic polymorphims in promoter region of osteopontin gene may be a marker reflecting hepatitis activity in chronic hepatitis C patients.

Authors:  Satoshi Mochida; Michie Hashimoto; Atsushi Matsui; Masashi Naito; Mie Inao; Sumiko Nagoshi; Makoto Nagano; Tohru Egashira; Shunji Mishiro; Kenji Fujiwara
Journal:  Biochem Biophys Res Commun       Date:  2004-01-23       Impact factor: 3.575

View more
  5 in total

1.  Association of osteopontin polymorphism with cancer risk: a meta-analysis.

Authors:  Gang Yang; Xiaoxing Peng; Pengju Guo; Ge Yang
Journal:  Int J Clin Exp Med       Date:  2015-11-15

2.  The Role of Osteopontin and Its Gene on Glucocorticoid Response in Myasthenia Gravis.

Authors:  Yanchen Xie; Hai-Feng Li; Liang Sun; Linda L Kusner; Shuhui Wang; Yunxiao Meng; Xu Zhang; Yu Hong; Xiang Gao; Yao Li; Henry J Kaminski
Journal:  Front Neurol       Date:  2017-05-31       Impact factor: 4.003

3.  Multiple functional SNPs in differentially expressed genes modify risk and survival of non-small cell lung cancer in Chinese female non-smokers.

Authors:  Xue Fang; Zhihua Yin; Xuelian Li; Lingzi Xia; Xiaowei Quan; Yuxia Zhao; Baosen Zhou
Journal:  Oncotarget       Date:  2017-03-21

4.  OPN gene polymorphisms, rs17524488 GG/G, rs11730582 T/C, and rs9138 C/A, and cancer risk in a Chinese population.

Authors:  Yuanyuan Mi; Kewei Ren; Feng Dai; Lijie Zhu; Ninghan Feng
Journal:  Sci Rep       Date:  2015-09-15       Impact factor: 4.379

5.  Associations between the Genetic Polymorphisms of Osteopontin Promoter and Susceptibility to Cancer in Chinese Population: A Meta-Analysis.

Authors:  Yulan Liu; Hongbo Lei; Jixiang Zhang; Jun Wang; Kui Li; Weiguo Dong
Journal:  PLoS One       Date:  2015-08-12       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.